| 摘要 |
Disclosed is a chimeric analog comprising formula (III) wherein Q is C or N, provided that when Q is N then R2 is absent; Z is a ligand of at least one somatostatin receptor as disclosed within the specification and wherein the rest of the substituents are disclosed within the specification. Also disclosed is the use in the manufacture of a medicament for treating a disease or condition responsive to a dopamine receptor agonist effect or to a somatostatin receptor agonist effect such as a neuroendocrine tumor; a vascular disease; a connective tissue disease; an immune disease; a disorder of the gastrointestinal tract, pancreas, kidney, or liver; a metabolic disease; a cachexia; cancer or a tumor of the lung, breast, prostate, liver, thyroid, blood; a musculoskeletal disorder; a panic disorder; and opioid overdose. (62) Divided Out of 542297
|
